ES2052476T3 - Procedimiento para la produccion de finasterida. - Google Patents

Procedimiento para la produccion de finasterida.

Info

Publication number
ES2052476T3
ES2052476T3 ES93203163T ES93203163T ES2052476T3 ES 2052476 T3 ES2052476 T3 ES 2052476T3 ES 93203163 T ES93203163 T ES 93203163T ES 93203163 T ES93203163 T ES 93203163T ES 2052476 T3 ES2052476 T3 ES 2052476T3
Authority
ES
Spain
Prior art keywords
finasteride
production
magnesium
halide
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93203163T
Other languages
English (en)
Other versions
ES2052476T5 (es
ES2052476T1 (es
Inventor
Ulf H Dolling
James A Mccauley
Richard J Varsolona
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26681536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2052476(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES2052476T1 publication Critical patent/ES2052476T1/es
Application granted granted Critical
Publication of ES2052476T3 publication Critical patent/ES2052476T3/es
Publication of ES2052476T5 publication Critical patent/ES2052476T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N5/00—Details of television systems
    • H04N5/74—Projection arrangements for image reproduction, e.g. using eidophor
    • H04N5/7416—Projection arrangements for image reproduction, e.g. using eidophor involving the use of a spatial light modulator, e.g. a light valve, controlled by a video signal
    • H04N5/7458—Projection arrangements for image reproduction, e.g. using eidophor involving the use of a spatial light modulator, e.g. a light valve, controlled by a video signal the modulator being an array of deformable mirrors, e.g. digital micromirror device [DMD]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Multimedia (AREA)
  • Signal Processing (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Dental Preparations (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE DESCRIBE UN NUEVO PROCESO PARA PRODUCIR FINASTERIDA QUE COMPRENDE REACCIONAR SAL DE HALURO DE MAGNESIO DE 17BETACARBOALCOXI-4AZA-5ALFA-ANDROST-1-EN-3-ONA CON HALURO DE MAGNESIO TBUTILAMINO, PRESENTE EN AL MENOS UNA PROPORCION 2:1 MOLAR AL ESTER, FORMADO DE T-BUTILO AMINO Y UN HALURO DE MAGNESIO ALIFATICO/AROMATICO A TEMPERATURA AMBIENTE EN UN DISOLVENTE ORGANICO INERTE BAJO UNA ATMOSFERA INERTE SEGUIDO DE EL CALENTAMIENTO Y RECUPERACION DE FINASTERIDE. TAMBIEN SE DESCRIBEN DOS FORMAS CRISTALINAS POLIMORFICAS I Y II DE FINASTERIDE, Y LOS METODOS DE PRODUCCION.
ES93203163T 1992-11-19 1993-11-12 Un procedimiento para la produccion de finasterida. Expired - Lifetime ES2052476T5 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US97853592A 1992-11-19 1992-11-19
US978535 1993-01-29
US08/010,734 US5468860A (en) 1992-11-19 1993-01-29 New finasteride processes
US10734 1993-01-29

Publications (3)

Publication Number Publication Date
ES2052476T1 ES2052476T1 (es) 1994-07-16
ES2052476T3 true ES2052476T3 (es) 1998-06-16
ES2052476T5 ES2052476T5 (es) 2008-11-01

Family

ID=26681536

Family Applications (2)

Application Number Title Priority Date Filing Date
ES95200270T Expired - Lifetime ES2072848T3 (es) 1992-11-19 1993-11-12 Nuevo procedimiento de preparacion de finasterida.
ES93203163T Expired - Lifetime ES2052476T5 (es) 1992-11-19 1993-11-12 Un procedimiento para la produccion de finasterida.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES95200270T Expired - Lifetime ES2072848T3 (es) 1992-11-19 1993-11-12 Nuevo procedimiento de preparacion de finasterida.

Country Status (32)

Country Link
US (3) US5468860A (es)
EP (3) EP0655458B1 (es)
JP (2) JPH07110875B2 (es)
CN (1) CN1058018C (es)
AT (2) ATE177112T1 (es)
AU (1) AU658774B2 (es)
BG (2) BG62362B1 (es)
CA (1) CA2103107C (es)
CY (1) CY2135B1 (es)
CZ (3) CZ301160B6 (es)
DE (4) DE69323754T2 (es)
DK (2) DK0599376T4 (es)
DZ (1) DZ1733A1 (es)
ES (2) ES2072848T3 (es)
FI (4) FI107450B (es)
GR (4) GR940300045T1 (es)
HR (2) HRP931410B1 (es)
HU (2) HU216195B (es)
IL (1) IL107574A (es)
IS (2) IS1692B (es)
LV (2) LV12212B (es)
MX (1) MX9307222A (es)
MY (2) MY110410A (es)
NO (3) NO305912B1 (es)
PH (1) PH31120A (es)
RO (2) RO115164B1 (es)
RU (1) RU2120445C1 (es)
SI (1) SI9300603B (es)
SK (2) SK286488B6 (es)
TW (1) TW257766B (es)
UA (1) UA41341C2 (es)
WO (1) WO1994011387A2 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
IT1270660B (it) * 1994-10-13 1997-05-07 Poli Ind Chimica Spa Procedimento microbiologico per la preparazione di 3-oxo-4-azasteroidi-17beta-carbossi sostituiti e uso dei prodotti come inibitori dell'enzima 5alfa-riduttasi
US5670643A (en) * 1995-03-16 1997-09-23 Glaxo Wellcome Inc. Method for preparing finasteride
US5585383A (en) * 1995-05-03 1996-12-17 Merck & Co., Inc. Process for crystallizing a 4-azasteroid 5alpha-reductase inhibitor
JPH11512434A (ja) * 1995-09-15 1999-10-26 メルク エンド カンパニー インコーポレーテッド アンドロゲン過剰状態治療用の４−アザステロイド
GB2338234B (en) * 1998-06-10 2000-05-03 Torcan Chemical Ltd Preparation of finasteride
ES2153789B1 (es) * 1999-07-05 2001-10-16 Raga Consultores S L Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides
EP1228084A1 (en) * 1999-11-01 2002-08-07 TORCAN CHEMICAL Ltd Production of polymorphic forms i and ii of finasteride by complexation with group i or ii metal salts
EP1790653A3 (en) * 2000-09-07 2010-06-02 Dr. Reddy's Laboratories Ltd. Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it
KR20030029947A (ko) * 2000-09-07 2003-04-16 닥터 레디스 레보러터리즈 리미티드 17-β-(엔-티-부틸카르바모일)-4-아자-5-α-안드로스트-1-엔-3-온의 신규의다형태 및 그 제조방법
PL361014A1 (en) * 2000-09-07 2004-09-20 Dr.Reddy's Laboratories Ltd. Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it
KR100415858B1 (ko) * 2001-09-22 2004-01-24 한미약품 주식회사 17베타-(엔-3차-부틸카바모일)-3-온 스테로이드 화합물의제조방법
CN100428897C (zh) * 2002-08-16 2008-10-29 浙江寿峰堂生物工程有限公司 抗疲劳改善亚健康的保健食品及其制备方法
ES2206065B1 (es) * 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.
AU2003217439A1 (en) * 2003-03-19 2004-10-11 Hetero Drugs Limited Novel crystalline forms of finasteride
US7550593B2 (en) * 2003-07-03 2009-06-23 Cipla Limited Process for the preparation of finasteride Form I
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
US20070167477A1 (en) * 2006-01-13 2007-07-19 Mandava Venkata Naga Brahmeswa Processes to prepare finasteride polymorphs
US7531658B2 (en) * 2006-01-20 2009-05-12 Apotex Pharmachem Inc. Process for the preparation of 17-N-substituted-carbamoyl-4-aza-androst-1-en-3-ones
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
KR101324578B1 (ko) 2006-02-03 2013-11-01 제이알 켐, 엘엘씨 구리 및 아연 조성물을 사용하는 노화 방지 치료법
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US20090076058A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched finasteride
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
ATE551604T1 (de) * 2008-05-05 2012-04-15 Abbott Gmbh & Co Kg Verfahren zur beurteilung der löslichkeit eines kristallinen stoffes in einem polymer
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
EP0285383B1 (en) * 1987-04-03 1994-03-16 Merck & Co. Inc. Treatment of prostatic carcinoma with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones
NZ225100A (en) 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5084574A (en) * 1988-04-18 1992-01-28 Merck & Co., Inc. Dehydrogenation process
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) * 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
ES2078447T3 (es) * 1990-06-15 1995-12-16 Merck & Co Inc Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales.
EP0462662A3 (en) * 1990-06-20 1992-08-19 Merck & Co. Inc. 17beta-n-monosubstituted adamantyl/norbornanyl carbamoyl-4-aza-5alpha-androst-1-en-3-ones and androstan-3-ones
US5120847A (en) † 1990-08-27 1992-06-09 Merck & Co., Inc. Process for iodinating or brominating the α-methylenic carbon of a secondary amide
US5091534A (en) 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
CA2050824A1 (en) * 1990-09-24 1992-03-25 John M. Williams Process for making 3-oxo-4-aza-androst-1-ene 17-.beta.-ketones
US5061801A (en) * 1990-09-24 1991-10-29 Merck & Co., Inc. Intermediate for making 3-oxo-4-aza-androst-1-ene 17β-ketones
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
CA2103107A1 (en) 1994-05-20
ES2052476T5 (es) 2008-11-01
FI20040559A7 (fi) 2004-04-21
NO990468L (no) 1995-05-19
JPH09235294A (ja) 1997-09-09
GR950300043T1 (en) 1995-07-31
SK65995A3 (en) 1995-10-11
CZ126895A3 (en) 1995-12-13
LV12212A (lv) 1999-01-20
CZ301191B6 (cs) 2009-12-02
AU658774B2 (en) 1995-04-27
PH31120A (en) 1998-02-23
LV12460A (lv) 2000-04-20
NO990468D0 (no) 1999-02-01
IL107574A0 (en) 1994-02-27
NO951986D0 (no) 1995-05-19
FI952422A0 (fi) 1995-05-18
HRP20000295B1 (en) 2002-08-31
HU210535A9 (en) 1995-04-28
SK281765B6 (sk) 2001-07-10
EP0823436A2 (en) 1998-02-11
MY110411A (en) 1998-05-30
EP0599376B1 (en) 1998-04-08
NO992580D0 (no) 1999-05-28
UA41341C2 (uk) 2001-09-17
GR3026577T3 (en) 1998-07-31
DE69323754D1 (de) 1999-04-08
NO307609B1 (no) 2000-05-02
BG64464B1 (bg) 2005-03-31
CN1090583A (zh) 1994-08-10
FI114215B (fi) 2004-09-15
EP0655458A2 (en) 1995-05-31
EP0655458B1 (en) 1999-03-03
FI952422L (fi) 1995-05-18
HRP931410A2 (en) 1996-06-30
IS4286A (is) 1994-05-20
HUT66973A (en) 1995-01-30
RO115164B1 (ro) 1999-11-30
NO951986L (no) 1995-05-19
HRP931410B1 (en) 2000-06-30
RU95112521A (ru) 1997-02-10
DK0655458T3 (da) 1999-09-27
DE69323754T2 (de) 1999-10-07
SK286488B6 (sk) 2008-11-06
FI107450B (fi) 2001-08-15
NO307888B1 (no) 2000-06-13
ATE177112T1 (de) 1999-03-15
CY2135B1 (en) 2002-05-21
GR3029554T3 (en) 1999-06-30
RU2120445C1 (ru) 1998-10-20
JP2742409B2 (ja) 1998-04-22
MY110410A (en) 1998-05-30
BG62362B1 (bg) 1999-09-30
DE69317856T2 (de) 1998-11-05
CN1058018C (zh) 2000-11-01
TW257766B (es) 1995-09-21
FI20010289L (fi) 2001-02-15
EP0823436A3 (en) 1998-11-25
JPH06199889A (ja) 1994-07-19
IS1692B (is) 1998-04-20
HU9303275D0 (en) 1994-03-28
DZ1733A1 (fr) 2002-02-17
CZ287842B6 (en) 2001-02-14
MX9307222A (es) 1994-07-29
ES2052476T1 (es) 1994-07-16
SI9300603B (sl) 2004-06-30
LV12212B (en) 1999-03-20
HK1008338A1 (en) 1999-05-07
DE69317856D1 (de) 1998-05-14
DE599376T1 (de) 1994-12-08
IS4094A (is) 1994-05-20
US5468860A (en) 1995-11-21
US5652365A (en) 1997-07-29
NO992580L (no) 1995-05-19
EP0599376A3 (en) 1994-09-28
EP0599376A2 (en) 1994-06-01
CA2103107C (en) 2010-09-28
AU5078793A (en) 1994-06-16
SI9300603A (en) 1994-06-30
JPH07110875B2 (ja) 1995-11-29
WO1994011387A3 (en) 1994-09-29
HRP20000295A2 (en) 2000-08-31
EP0599376B2 (en) 2008-04-16
FI114800B (fi) 2004-12-31
FI116941B (fi) 2006-04-13
RO115165B1 (ro) 1999-11-30
GR940300045T1 (en) 1994-07-29
DK0599376T4 (da) 2008-07-28
US5886184A (en) 1999-03-23
HU216195B (hu) 1999-05-28
IL107574A (en) 2000-07-16
CZ301160B6 (cs) 2009-11-18
BG103170A (en) 1999-09-30
NO307888B3 (no) 2000-06-13
ES2072848T1 (es) 1995-08-01
ATE164850T1 (de) 1998-04-15
ES2072848T3 (es) 1999-05-01
LV12460B (en) 2000-09-20
BG99637A (bg) 1996-04-30
EP0655458A3 (en) 1996-07-10
IS1671B (is) 1997-12-19
FI20010290L (fi) 2001-02-15
DE655458T1 (de) 1995-11-30
WO1994011387A2 (en) 1994-05-26
NO305912B1 (no) 1999-08-16

Similar Documents

Publication Publication Date Title
ES2052476T3 (es) Procedimiento para la produccion de finasterida.
ES8606879A1 (es) Un procedimiento para la preparacion de derivados esteroida-les
ES8403453A1 (es) Un procedimiento para preparar amidas del acido 1-metil-5-p-toluoilpirrol-2-acetico.
ES462677A1 (es) Procedimiento de recuperacion del galio contenido en solu- ciones acuosas muy basicas.
ES8507498A1 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
DK159786A (da) Fremgangsmaade til fremstilling af en krystallinsk form af natriumsalatet af et oximderivat af 7-aminothiazolylacetamidocephalosporansyre
IT1034702B (it) Processo per la carbossilazione di substrati organici con anidri de carbonica.
ES469423A1 (es) Un procedimiento para la produccion de los antibioticos antitumorales ma 144-m1 o 144-m2.
ES8204410A1 (es) Procedimiento de obtencion de derivados de acido fenilaceti-co
DK604288D0 (da) Fremgangsmaade til fremstilling af trans-1,,1,2-triphenyl-but-1-en-derivater
GB1208251A (en) PROCESS FOR THE PREPARATION OF N-CARBOXYLIC ACID ANHYDRIDES OF GLUTAMIC ACID-gamma-ESTERS
EP0319814A3 (en) Method of preparing asymmetrical dihydropyridines
GR3002989T3 (en) Process for the production of n-acylated mercapto-alpha-amino acids
JPS55154950A (en) Novel carboxylic acid amide derivative
ES8203015A1 (es) Procedimiento para preparar un solvato de amoxicilina sodicacon n-metil-2-metil-pirrolidona
DK0661263T3 (da) Fremgangsmåde til fremstilling af 2,4,5-tribrompyrrol-3-carbonitril
JPS6445393A (en) Estradiol derivative
ES8103733A1 (es) Un procedimiento para la preparacion de acido 6-cloro-alfa- metil-carbazol-2-acetico
GB2009158A (en) Thienylmalonic Acid and Diesters Thereof
SE7601714L (sv) Substituerade indanylpropionsyror
JPS5277003A (en) Stabilization process of peroxyketones
JPS5212107A (en) Process for preparation of farnesol or its 10,11-isopropylidenedioxy d erivative
CA2098959A1 (en) Compounds and methods for the site-specific photoaffinity labelling of biomolecules
GB2009224A (en) Process for The Manufacture of O-Benzyl Toluenes
DK0581797T3 (da) Hidtil ukendte thiophen-2-carboxylsyrederivater og fremgangsmåde til deres fremstillng

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 599376

Country of ref document: ES